| Literature DB >> 8762643 |
S Abdul-Hadi1, R Contreras, C Tombazzi, M Alvarez, M Melendez.
Abstract
A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8762643 DOI: 10.1590/s0036-46651996000100013
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846